METTL3 and lung cancer: A number of recent studies demonstrate that m6A modification is a key player in radioresistance in cancer cells (Table10).[118] m6A modification due to METTL3 upregulation in non‐small cell lung cancer is implicated in resistance to carbon‐ion radiotherapy.